SARS-CoV-2.

Ramsey Bekdash1,2,3, Kazushige Yoshida1,2, Manoj S Nair4

  • 1Department of Rehabilitation and Regenerative Medicine, Columbia University, New York, New York, United States of America.

PLoS biology
|March 14, 2024
PubMed
概括

研究人员开发了新型,iPep-SARS2-E,针对保存的SARS-CoV-2信封蛋白. 这些有效地抑制了体外和体内病毒的传播和细胞毒性,为冠状病毒提供了潜在的治疗策略.